Uniqure NV (QURE) support and resistance · rev $16.1M
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
This page maps Uniqure NV (QURE) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
QURE currently screens at market cap $3.04B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new QURE 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the QURE quote page for the session range and the stock page for the full model.
Not investment advice.